Sequencing and analysis of globally obtained human parainfluenza viruses 1 and 3 genomes

Autor: Martha I. Nelson, Neha Gupta, Paolo Amedeo, Kelly J. Henrickson, Christopher D. Town, Samuel Cordey, Daniel E. Noyola, Cristina Videla, Susmita Shrivastava, Tuckweng Kok, Astrid Vabret, Rebecca A. Halpin, Michael E. Bose, Nadia Fedorova, Hernan Lorenzi, Marietjie Venter, Amelia Buys, Jie He, Jayati Bera
Přispěvatelé: Medical College of Wisconsin [Milwaukee] (MCW), J. Craig Venter Institute, Fogarty International Center, National Institutes of Health [Bethesda] (NIH), Universidad Autonoma de San Luis Potosi [México] (UASLP), Centro de Educación Médica e Investigaciones Clínicas (CEMIC), University of South Australia [Adelaide], National Institute for Communicable Diseases [Johannesburg] (NICD), University of Pretoria [South Africa], Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Université de Caen Normandie (UNICAEN), Normandie Université (NU), Service de Virologie [CHU Caen], CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Geneva University Hospital (HUG)
Jazyk: angličtina
Rok vydání: 2019
Předmět:
RNA viruses
0301 basic medicine
medicine.disease_cause
Genome
Database and Informatics Methods
Influenza A virus
Genome Evolution
Phylogeny
Pathology and laboratory medicine
ComputingMilieux_MISCELLANEOUS
Data Management
ddc:616
Recombination
Genetic

Genetics
Multidisciplinary
High-Throughput Nucleotide Sequencing
Phylogenetic Analysis
Genomics
Medical microbiology
3. Good health
Phylogenetics
Human Parainfluenza Virus
Viruses
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Evolutionary Rate
Medicine
Pathogens
Sequence Analysis
Research Article
Computer and Information Sciences
Evolutionary Processes
Bioinformatics
Sequence analysis
Science
030106 microbiology
Genome
Viral

Biology
Research and Analysis Methods
Microbiology
Molecular Evolution
Virus
Evolution
Molecular

03 medical and health sciences
Sequence Motif Analysis
medicine
Humans
Influenza viruses
Evolutionary Systematics
Parainfluenza Virus 1
Human/genetics

Selection
Genetic

Taxonomy
Medicine and health sciences
Evolutionary Biology
Sequence Assembly Tools
Organisms
Viral pathogens
Biology and Life Sciences
Computational Biology
Sequence Analysis
DNA

Ion semiconductor sequencing
Genome Analysis
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
Genomics/methods
Parainfluenza Virus 1
Human

Parainfluenza Virus 3
Human

Microbial pathogens
030104 developmental biology
Parainfluenza Virus 3
Human/genetics

Sequence Alignment
Orthomyxoviruses
Zdroj: PLoS ONE
PLoS ONE, Public Library of Science, 2019, 14 (7), pp.e0220057. ⟨10.1371/journal.pone.0220057⟩
PLoS ONE, Vol 14, Iss 7, p e0220057 (2019)
PLOS ONE, Vol. 14, No 7 (2019) P. e0220057
ISSN: 1932-6203
Popis: Human Parainfluenza viruses (HPIV) type 1 and 3 are important causes of respiratory tract infections in young children globally. HPIV infections do not confer complete protective immunity so reinfections occur throughout life. Since no effective vaccine is available for the two virus subtypes, comprehensive understanding of HPIV-1 and HPIV-3 genetic and epidemic features is important for diagnosis, prevention, and treatment of HPIV-1 and HPIV-3 infections. Relatively few whole genome sequences are available for both HPIV-1 and HPIV-3 viruses, so our study sought to provide whole genome sequences from multiple countries to further the understanding of the global diversity of HPIV at a whole-genome level. We collected HPIV-1 and HPIV-3 samples and isolates from Argentina, Australia, France, Mexico, South Africa, Switzerland, and USA from the years 2003-2011 and sequenced the genomes of 40 HPIV-1 and 75 HPIV-3 viruses with Sanger and next-generation sequencing with the Ion Torrent, Illumina, and 454 platforms. Phylogenetic analysis showed that the HPIV-1 genome is evolving at an estimated rate of 4.97 × 10-4 mutations/site/year (95% highest posterior density 4.55 × 10-4 to 5.38 × 10-4) and the HPIV-3 genome is evolving at a similar rate (3.59 × 10-4 mutations/site/year, 95% highest posterior density 3.26 × 10-4 to 3.94 × 10-4). There were multiple genetically distinct lineages of both HPIV-1 and 3 circulating on a global scale. Further surveillance and whole-genome sequencing are greatly needed to better understand the spatial dynamics of these important respiratory viruses in humans.
Databáze: OpenAIRE